A carregar...
Mesalazine allergy and an attempt at desensitization therapy in patients with inflammatory bowel disease
Mesalazine is a key drug used for remission induction and maintenance therapy in inflammatory bowel disease (IBD). We sometimes encounter patients who develop allergic reactions to the drug and inevitably discontinue treatment. Of 692 patients who received mesalazine for IBD between 2014 and March 2...
Na minha lista:
| Publicado no: | Sci Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7747557/ https://ncbi.nlm.nih.gov/pubmed/33335169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-79207-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|